Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$708K Buy
5,509
+225
+4% +$26.3K 0.28% 63
2026
Q1
$636K Hold
5,284
0.32% 64
2025
Q4
$556K Hold
5,284
0.3% 71
2025
Q3
$443K Buy
5,284
+175
+3% +$14.4K 0.24% 83
2025
Q2
$404K Buy
5,109
+279
+6% +$22.2K 0.23% 87
2025
Q1
$434K Buy
4,830
+638
+15% +$59.6K 0.28% 78
2024
Q4
$417K Sell
4,192
-137
-3% -$14.1K 0.29% 78
2024
Q3
$492K Sell
4,329
-22
-0.5% -$2.61K 0.34% 64
2024
Q2
$539K Sell
4,351
-15
-0.3% -$1.93K 0.4% 56
2024
Q1
$576K Buy
4,366
+105
+2% +$12.9K 0.44% 52
2023
Q4
$465K Sell
4,261
-506
-11% -$52.5K 0.37% 58
2023
Q3
$491K Sell
4,767
-3
-0.1% -$323 0.43% 53
2023
Q2
$550K Sell
4,770
-135
-3% -$15.3K 0.45% 50
2023
Q1
$522K Sell
4,905
-145
-3% -$15.7K 0.45% 51
2022
Q4
$560K Sell
5,050
-2
-0% -$204 0.47% 49
2022
Q3
$435K Sell
5,052
-71
-1% -$6.34K 0.39% 60
2022
Q2
$467K Buy
5,123
+938
+22% +$83.2K 0.44% 53
2022
Q1
$343K Hold
4,185
0.31% 69
2021
Q4
$321K Hold
4,185
0.28% 73
2021
Q3
$314K Buy
+4,185
New +$318K 0.3% 72
2021
Q1
$420K Buy
+5,717
New +$422K 0.41% 52

Other funds holding MRK

First Bancorp's MRK Position: Q2 2026 in Review

First Bancorp increased its Merck (MRK) stake by 4.3% in Q2 2026, buying an estimated $26.3K and bringing the position to 5,509 shares worth $708K. The position accounts for 0.28% of the portfolio, ranked #63.

First Bancorp first reported a position in MRK in Q1 2021 and has held it in 21 quarters since. 3,841 funds tracked by Wall St. Rank hold MRK as of Q2 2026.

  • First Bancorp held 5,509 shares of Merck worth $708K as of Q2 2026.
  • First Bancorp bought 225 Merck shares in Q2 2026, an estimated $26.3K.
  • Merck made up 0.28% of First Bancorp's portfolio in Q2 2026, its #63 holding.
  • First Bancorp first reported a position in Merck in Q1 2021 and has held it in 21 quarters since.
  • 3,841 funds tracked by Wall St. Rank held Merck as of Q2 2026.

Based on First Bancorp's 13F filing for Q2 2026, filed 11 Aug 2026.